{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T07:49:40Z","timestamp":1769154580390,"version":"3.49.0"},"reference-count":26,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"12","funder":[{"name":"Bertarelli Rare Cancers Initiative","award":["Not applicable"],"award-info":[{"award-number":["Not applicable"]}]}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,12]]},"abstract":"<jats:p>\n                    Dendritic cell neurofibroma with pseudorosettes is an uncommon but distinctive variant of neurofibroma. The pseudorosette structures are formed by the circumferential arrangement of small, dark cells around an eosinophilic core at the center of which there is often a single larger and paler cell with slender dendrite-like projections. Dendritic cell neurofibroma often shows a multinodular architecture, which can cause confusion with plexiform neurofibroma. Since plexiform neurofibroma is essentially pathognomonic of Neurofibromatosis type I, such confusion could lead to unnecessary and costly clinical work-up. Since its description in 2001, there has been controversy as to whether dendritic cell neurofibroma represents a true subtype of neurofibroma, whose defining molecular feature is loss-of-function mutation in\n                    <jats:italic toggle=\"yes\">NF1<\/jats:italic>\n                    . Here we show in a series of 9 cases that dendritic cell neurofibroma harbors recurrent gene fusions involving protein kinase c-alpha (\n                    <jats:italic toggle=\"yes\">PRKCA<\/jats:italic>\n                    ), including\n                    <jats:italic toggle=\"yes\">SLC44A1::PRKCA<\/jats:italic>\n                    . Identical gene fusions are known to occur in a rare brain tumor known as papillary glioneuronal tumor, although this entity appears to be morphologically and clinically distinct from dendritic cell neurofibroma. Our results distinguish dendritic cell neurofibroma from conventional types of neurofibroma and raise consideration that dendritic cell neurofibroma may be better classified as a unique type of benign neural tumor.\n                  <\/jats:p>","DOI":"10.1097\/pas.0000000000002460","type":"journal-article","created":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T07:00:13Z","timestamp":1753858813000},"page":"1251-1257","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Protein Kinase C-alpha Gene Fusions in Dendritic Cell Neurofibroma"],"prefix":"10.1097","volume":"49","author":[{"given":"Arnaud","family":"de la Fouchardiere","sequence":"first","affiliation":[{"name":"Department of Biopathology, INSERM 1052, CNRS 5286, Cancer Research Center of Lyon"},{"name":"Department of Biopathology, Centre Leon Bernard, Lyon, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth C.","family":"Draper","sequence":"additional","affiliation":[{"name":"Department of Pathology, Brigham and Women\u2019s Hospital and Harvard Medical School, Boston, MA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Pissaloux","sequence":"additional","affiliation":[{"name":"Department of Biopathology, INSERM 1052, CNRS 5286, Cancer Research Center of Lyon"},{"name":"Department of Biopathology, Centre Leon Bernard, Lyon, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marshall","family":"Lukacs","sequence":"additional","affiliation":[{"name":"Department of Pathology, Brigham and Women\u2019s Hospital and Harvard Medical School, Boston, MA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Franck","family":"Tirode","sequence":"additional","affiliation":[{"name":"Department of Biopathology, Centre Leon Bernard, Lyon, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John","family":"Hanna","sequence":"additional","affiliation":[{"name":"Department of Pathology, Brigham and Women\u2019s Hospital and Harvard Medical School, Boston, MA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2025,7,25]]},"reference":[{"key":"R1-20251112","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1093\/jnen\/63.11.1115","article-title":"Tumor suppressor mutations and growth factor signaling in the pathogenesis of NF1-associated peripheral nerve sheath tumors. I. The role of tumor suppressor mutations","volume":"63","author":"Carroll","year":"2004","journal-title":"J Neuropathol Exp Neurol"},{"key":"R2-20251112","doi-asserted-by":"crossref","first-page":"2172","DOI":"10.1126\/science.286.5447.2172","article-title":"Mouse models of tumor development in neurofibromatosis type 1","volume":"286","author":"Cichowski","year":"1999","journal-title":"Science"},{"key":"R3-20251112","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1097\/00000478-200105000-00004","article-title":"Dendritic cell neurofibroma with pseudorosettes: a report of 18 cases of a distinct and hitherto unrecognized neurofibroma variant","volume":"25","author":"Michal","year":"2001","journal-title":"Am J Surg Pathol"},{"key":"R4-20251112","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1111\/1346-8138.12690","article-title":"Four Japanese cases of dendritic cell neurofibroma with pseudorosettes","volume":"41","author":"Hattori","year":"2014","journal-title":"J Dermatol"},{"key":"R5-20251112","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1111\/cup.14011","article-title":"Dendritic cell neurofibroma with pseudorosettes","volume":"49","author":"Ramos","year":"2022","journal-title":"J Cutan Pathol"},{"key":"R6-20251112","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1097\/01.dad.0000157462.49463.b8","article-title":"Dendritic cell neurofibroma with pseudorosettes lacks mutations in exons 1-15 of the neurofibromatosis type 2 gene","volume":"27","author":"Kazakov","year":"2005","journal-title":"Am J Dermatopathol"},{"key":"R7-20251112","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1097\/00000478-200111000-00017","article-title":"Dendritic cell neurofibroma with pseudorosettes: two tumors in a patient with evidence of neurofibromatosis","volume":"25","author":"Simpson","year":"2001","journal-title":"Am J Surg Pathol"},{"key":"R8-20251112","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1097\/00000478-200212000-00015","article-title":"Histologically benign cutaneous dendritic cell tumor with pseudorosettes","volume":"26","author":"Woodruff","year":"2002","journal-title":"Am J Surg Pathol"},{"key":"R9-20251112","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1097\/00000478-200212000-00016","article-title":"Histologically benign cutaneous dendritic cell tumor with pseudorosettes","volume":"26","author":"Michal","year":"2002","journal-title":"Am J Surg Pathol"},{"key":"R10-20251112","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1097\/DAD.0000000000001665","article-title":"Dendritic cell neurofibroma with pseudorosettes: a variant of neurofibroma?","volume":"43","author":"Saggini","year":"2021","journal-title":"Am J Dermatopathol"},{"key":"R11-20251112","doi-asserted-by":"crossref","first-page":"e87062","DOI":"10.1172\/jci.insight.87062","article-title":"Institutional implementation of clinical tumor profiling on an unselected cancer population","volume":"1","author":"Sholl","year":"2016","journal-title":"JCI Insight"},{"key":"R12-20251112","doi-asserted-by":"crossref","first-page":"751","DOI":"10.5858\/arpa.2016-0527-OA","article-title":"Validation of OncoPanel: a targeted next-generation sequencing assay for the detection of somatic variants in cancer","volume":"141","author":"Garcia","year":"2017","journal-title":"Arch Pathol Lab Med"},{"key":"R13-20251112","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1097\/DAD.0000000000001393","article-title":"Differential expression of PLAG1 in apocrine and eccrine cutaneous mixed tumors: evidence for distinct molecular pathogenesis","volume":"42","author":"Russell-Goldman","year":"2020","journal-title":"Am J Dermatopathol"},{"key":"R14-20251112","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1007\/s00428-021-03027-3","article-title":"Clear cell tumor with melanocytic differentiation and MITF-CREM translocation: a novel entity similar to clear cell sarcoma","volume":"479","author":"de la Fouchardiere","year":"2021","journal-title":"Virchows Arch"},{"key":"R15-20251112","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1097\/PAS.0000000000001952","article-title":"Cutaneous melanocytic tumor with CRTC1::TRIM11 translocation : an emerging entity analyzed in a series of 41 cases","volume":"46","author":"Hanna","year":"2022","journal-title":"Am J Surg Pathol"},{"key":"R16-20251112","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1002\/gcc.23026","article-title":"Wholistic approach: transcriptomic analysis and beyond using archival material for molecular diagnosis","volume":"61","author":"Macagno","year":"2022","journal-title":"Genes Chromosomes Cancer"},{"key":"R17-20251112","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1111\/cup.14427","article-title":"Clear cell tumor with melanocytic differentiation and MITF::CREM translocation","volume":"50","author":"Alexandrescu","year":"2023","journal-title":"J Cutan Pathol"},{"key":"R18-20251112","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1111\/j.1750-3639.2012.00612.x","article-title":"Identification of a novel, recurrent SLC44A1-PRKCA fusion in papillary glioneuronal tumor","volume":"23","author":"Bridge","year":"2013","journal-title":"Brain Pathol"},{"key":"R19-20251112","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1186\/s40478-015-0264-5","article-title":"Papillary glioneuronal tumors: histological and molecular characteristics and diagnostic value of SLC44A1-PRKCA fusion","volume":"3","author":"Pages","year":"2015","journal-title":"Acta Neuropathol Commun"},{"key":"R20-20251112","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.jocn.2015.04.021","article-title":"SLC44A1-PRKCA fusion in papillary and rosette-forming glioneuronal tumors","volume":"23","author":"Nagaishi","year":"2016","journal-title":"J Clin Neurosci"},{"key":"R21-20251112","doi-asserted-by":"crossref","first-page":"100286","DOI":"10.1016\/j.modpat.2023.100286","article-title":"Histologic and genetic features of 51 melanocytic neoplasms with protein kinase C fusion genes","volume":"36","author":"de la Fouchardi\u00e8re","year":"2023","journal-title":"Mod Pathol"},{"key":"R22-20251112","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1097\/PAS.0000000000002262","article-title":"PRKC fusion melanocytic tumors, a subgroup of melanocytic tumors more closely aligned to blue nevi than to PRKAR1A-inactivated pigmented epithelioid melanocytomas","volume":"48","author":"Patel","year":"2024","journal-title":"Am J Surg Pathol"},{"key":"R23-20251112","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1111\/cup.14801","article-title":"Genomic and transcriptomic characterization of protein kinase c fusion melanocytic neoplasms with distinctive hypopigmented histomorphology: a single-institution study","volume":"52","author":"Li","year":"2025","journal-title":"J Cutan Pathol"},{"key":"R24-20251112","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1136\/jcp-2023-208867","article-title":"EWSR1: the promiscuous king of mesenchymal neoplasia","volume":"77","author":"Towery","year":"2024","journal-title":"J Clin Pathol"},{"key":"R25-20251112","doi-asserted-by":"crossref","first-page":"100769","DOI":"10.1016\/j.jbior.2020.100769","article-title":"The complexities of PKC\u03b1 signaling in cancer","volume":"80","author":"Black","year":"2021","journal-title":"Adv Biol Regul"},{"key":"R26-20251112","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1091\/mbc.E19-07-0392","article-title":"Dysregulation of very-long-chain fatty acid metabolism causes membrane saturation and induction of the unfolded protein response","volume":"31","author":"Micoogullari","year":"2020","journal-title":"Mol Biol Cell"}],"container-title":["American Journal of Surgical Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/PAS.0000000000002460","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T06:00:45Z","timestamp":1762927245000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/PAS.0000000000002460"}},"subtitle":["Distinction From Conventional Neurofibroma"],"short-title":[],"issued":{"date-parts":[[2025,7,25]]},"references-count":26,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/pas.0000000000002460","relation":{},"ISSN":["0147-5185","1532-0979"],"issn-type":[{"value":"0147-5185","type":"print"},{"value":"1532-0979","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,25]]}}}